DK3202420T3 - Transdermale farmaceutiske sammensætninger omfattende en serm - Google Patents

Transdermale farmaceutiske sammensætninger omfattende en serm Download PDF

Info

Publication number
DK3202420T3
DK3202420T3 DK17157911.3T DK17157911T DK3202420T3 DK 3202420 T3 DK3202420 T3 DK 3202420T3 DK 17157911 T DK17157911 T DK 17157911T DK 3202420 T3 DK3202420 T3 DK 3202420T3
Authority
DK
Denmark
Prior art keywords
serm
pharmaceutical compositions
compositions including
transdermal pharmaceutical
transdermal
Prior art date
Application number
DK17157911.3T
Other languages
English (en)
Inventor
Valérie Masini-Eteve
Original Assignee
Besins Healthcare Lu Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins Healthcare Lu Sarl filed Critical Besins Healthcare Lu Sarl
Application granted granted Critical
Publication of DK3202420T3 publication Critical patent/DK3202420T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0041Mammary glands, e.g. breasts, udder; Intramammary administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK17157911.3T 2008-12-11 2009-12-09 Transdermale farmaceutiske sammensætninger omfattende en serm DK3202420T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12184808P 2008-12-11 2008-12-11
EP08305924 2008-12-11
EP09764869.5A EP2373305B1 (en) 2008-12-11 2009-12-09 Transdermal pharmaceutical compositions comprising a serm

Publications (1)

Publication Number Publication Date
DK3202420T3 true DK3202420T3 (da) 2020-04-06

Family

ID=40521639

Family Applications (2)

Application Number Title Priority Date Filing Date
DK09764869.5T DK2373305T3 (da) 2008-12-11 2009-12-09 Transdermale farmaceutiske sammensætninger omfattende en serm
DK17157911.3T DK3202420T3 (da) 2008-12-11 2009-12-09 Transdermale farmaceutiske sammensætninger omfattende en serm

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK09764869.5T DK2373305T3 (da) 2008-12-11 2009-12-09 Transdermale farmaceutiske sammensætninger omfattende en serm

Country Status (9)

Country Link
US (2) US20120010245A1 (da)
EP (3) EP3202420B1 (da)
DK (2) DK2373305T3 (da)
ES (1) ES2624557T3 (da)
HU (1) HUE034680T2 (da)
PL (1) PL3202420T3 (da)
PT (1) PT2373305T (da)
SI (2) SI3202420T1 (da)
WO (1) WO2010066810A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10080760B2 (en) 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents
WO2015179282A1 (en) * 2014-05-20 2015-11-26 Topokine Therapeutics, Inc. Topical compositions comprising a thiazolidinedione
WO2015199677A1 (en) * 2014-06-25 2015-12-30 Hewlett Packard Development Company, L.P. Documentation notification
US20180200206A1 (en) * 2015-07-14 2018-07-19 Atossa Genetics Inc. Transpapillary methods and compositions for treating breast disorders
US20170304232A1 (en) 2016-04-20 2017-10-26 Northwestern University Endoxifen For Local Transdermal Therapy To The Breast
KR20240155974A (ko) 2017-09-11 2024-10-29 아토사 테라퓨틱스, 인크. 엔독시펜을 제조 및 사용하는 방법
CA3074302A1 (en) * 2017-09-11 2019-03-14 Atossa Therapeutics, Inc. Topical compositions and methods for treatment
CA3145867A1 (en) 2019-07-03 2021-01-07 Atossa Therapeutics, Inc. Sustained release compositions of endoxifen
GB2608397B (en) * 2021-06-29 2025-04-09 Chaitowitz Ilan Gynecomastia treatment

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207437D0 (en) * 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites
DE4407742C1 (de) * 1994-03-08 1995-06-22 Hexal Pharma Gmbh Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
FR2718372B1 (fr) 1994-04-08 1996-06-28 Sofab Dispensateur de produits fluides.
FR2723356B1 (fr) 1994-08-08 1996-10-18 Innovation Rech Plastique Sa Dispositif de conditionnement d'un produit avec pompe manuelle de distribution en doses unitaires
FR2726810B1 (fr) 1994-11-10 1997-01-31 Soc D Promotion Rech Et Innova Pompe doseuse a commande manuelle pour flacon a enveloppe deformable
IL120268A0 (en) * 1996-02-28 1997-06-10 Pfizer Use of (E)-1-[4'-(2-alkylaminoethioxy)phenyl]1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions
UA57596C2 (uk) * 1996-03-26 2003-06-16 Елі Ліллі Енд Компані Похідне бензотіофену, фармацевтична лікарська форма, фармацевтична композиція, спосіб лікування остеопорозу та спосіб зниження рівнів ліпідів
US5747509A (en) * 1996-06-03 1998-05-05 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)
EP1510213B1 (en) * 1997-11-10 2008-12-31 Strakan International Limited Penetration enhancing and irritation reducing systems comprising testosterone
FI982733A7 (fi) * 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
US6582724B2 (en) * 1999-12-16 2003-06-24 Dermatrends, Inc. Dual enhancer composition for topical and transdermal drug delivery
FR2851470B1 (fr) * 2003-02-20 2007-11-16 Besins Int Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse
EP1634583A1 (en) * 2004-09-09 2006-03-15 Laboratoires Besins International Testosterone gels comprising propylene glycol as penetration enhancer
WO2006125642A1 (en) * 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
US20070264349A1 (en) * 2006-03-07 2007-11-15 Novavax, Inc. Nano-structured compositions and methods of making and using the same
US20080220068A1 (en) * 2006-07-31 2008-09-11 Laboratories Besins International Treatment and prevention of excessive scarring
WO2008039864A1 (en) * 2006-09-26 2008-04-03 Novavax, Inc. Emulsion formulations for transdermal delivery of poorly water soluble active agents
HUE037109T2 (hu) * 2006-11-21 2018-08-28 Jina Pharmaceuticals Inc Endoxifén rák kezelésében történõ alkalmazásra

Also Published As

Publication number Publication date
US20190380948A1 (en) 2019-12-19
PL3202420T3 (pl) 2020-07-13
EP2373305B1 (en) 2017-03-15
DK2373305T3 (da) 2017-05-15
EP3202420B1 (en) 2020-03-04
EP2373305A1 (en) 2011-10-12
PT2373305T (pt) 2017-06-14
EP3656376A1 (en) 2020-05-27
ES2624557T3 (es) 2017-07-14
WO2010066810A1 (en) 2010-06-17
EP3202420A1 (en) 2017-08-09
US20120010245A1 (en) 2012-01-12
SI2373305T1 (sl) 2017-09-29
HUE034680T2 (en) 2018-02-28
SI3202420T1 (sl) 2020-08-31
WO2010066810A8 (en) 2010-10-21

Similar Documents

Publication Publication Date Title
LTPA2018005I1 (lt) Farmacinė kompozicija
DK3097925T3 (da) Farmaceutisk sammensætning
BRPI1004940A2 (pt) composição farmacêutica
PL2468281T3 (pl) Kompozycja farmaceutyczna zawierająca pochodną chinoliny
SMT201700095B (is) Composizioni farmaceutiche per inalazione
EP2240022A4 (en) PHARMACEUTICAL COMPOSITIONS
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
BRPI1012539A2 (pt) composições farmacêuticas
BRPI0721651A2 (pt) Composição farmacêutica
EP2451274A4 (en) Pharmaceutical compositions
EP2373681A4 (en) PHARMACEUTICAL COMPOSITIONS
DK4159204T3 (da) Hidtil ukendt farmaceutisk sammensætning
BRPI1015939A2 (pt) composição farmacêutica
DK3202420T3 (da) Transdermale farmaceutiske sammensætninger omfattende en serm
DK2285413T3 (da) Farmaceutisk sammensætning
EP2236149A4 (en) MEDICAL COMPOSITION
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
DK2120884T3 (da) Farmaceutisk sammensætning
IT1394400B1 (it) Composizioni farmaceutiche
BRPI0921654A2 (pt) formulação farmacêutica
BRPI0921313A2 (pt) composição farmaucêutica
EP2280032A4 (en) PHOTOPOLYMERIZABLE COMPOSITIONS
DK2271618T3 (da) Farmaceutiske forbindelser
BRPI0820198A2 (pt) composições farmacêuticas
BR112012003149A2 (pt) composição farmacêutica